Varian Medical Systems, Inc. (VAR)’s EVP and Pres. Oncology Sys. Kolleen Kennedy Sold 3,513 Shares of the Company; Davis Selected Advisers Increased By $440,820 Its Goldman Sachs Group (GS) Stake

In an electronic document that has been filled with the SEC, it was made public that the EVP and Pres. Oncology Sys. of Varian Medical Systems Inc Kolleen Kennedy, an insider in focus, made an open market transaction for 3,513 shares of the Pinksheet-listed company, having a total value of $425,622 U.S. Dollars using an average price-per-share of $121.2 U.S. Dollars. She also sold 10,412 shares that are worth approx $1,196,043 USD in the last 30 days. The possibility that this transaction remains a secret is very low because of the massive amount of cash involved. At present, Kolleen Kennedy owns 26,662 shares which are about 0.03% of the Company’s total market cap.

Davis Selected Advisers increased Goldman Sachs Group Inc. (GS) stake by 0.74% reported in 2017Q3 SEC filing. Davis Selected Advisers acquired 1,860 shares as Goldman Sachs Group Inc. (GS)’s stock declined 13.97%. The Davis Selected Advisers holds 252,986 shares with $60.01 million value, up from 251,126 last quarter. Goldman Sachs Group Inc. now has $100.95 billion valuation. The stock decreased 0.02% or $0.06 during the last trading session, reaching $267.62. About 2.60 million shares traded. The Goldman Sachs Group, Inc. (NYSE:GS) has risen 39.23% since February 17, 2017 and is uptrending. It has outperformed by 22.53% the S&P500.

Davis Selected Advisers decreased Baidu Inc. Class A Adr (NASDAQ:BIDU) stake by 2,316 shares to 83,789 valued at $20.75M in 2017Q3. It also reduced Oracle Corporation (NYSE:ORCL) stake by 109,799 shares and now owns 3.92M shares. Loews Corp. (NYSE:L) was reduced too.

Investors sentiment decreased to 0.75 in Q3 2017. Its down 0.33, from 1.08 in 2017Q2. It fall, as 63 investors sold GS shares while 427 reduced holdings. 82 funds opened positions while 285 raised stakes. 271.74 million shares or 2.47% less from 278.62 million shares in 2017Q2 were reported. Kentucky Retirement Tru Fund holds 9,680 shares. Autus Asset Limited holds 0.65% or 14,276 shares. Burke And Herbert Bancorp And Tru has invested 0.35% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Telemus Limited Liability Company has 0.06% invested in The Goldman Sachs Group, Inc. (NYSE:GS) for 1,476 shares. Ibm Retirement Fund stated it has 9,137 shares or 0.44% of all its holdings. Clarivest Asset Llc invested 0% in The Goldman Sachs Group, Inc. (NYSE:GS). Hennessy Advsrs holds 0.04% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS) for 6,000 shares. Ontario – Canada-based Cibc World Markets has invested 0.21% in The Goldman Sachs Group, Inc. (NYSE:GS). Natl Pension Service accumulated 0.38% or 289,523 shares. Steinberg Global Asset Management reported 0.04% in The Goldman Sachs Group, Inc. (NYSE:GS). Ally Fin invested 1.04% in The Goldman Sachs Group, Inc. (NYSE:GS). National Asset invested 0.17% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Moreover, Colony Gp Ltd Liability Corp has 0.13% invested in The Goldman Sachs Group, Inc. (NYSE:GS) for 7,720 shares. Natixis Asset invested 0.08% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Grandfield & Dodd Lc has 1,929 shares for 0.05% of their portfolio.

Among 30 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 13 have Buy rating, 1 Sell and 16 Hold. Therefore 43% are positive. Goldman Sachs Group Inc. has $320 highest and $140 lowest target. $247.61’s average target is -7.48% below currents $267.62 stock price. Goldman Sachs Group Inc. had 97 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by JP Morgan on Tuesday, February 16 to “Overweight”. Rafferty downgraded the stock to “Hold” rating in Wednesday, April 19 report. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) has “Hold” rating given on Tuesday, July 18 by BMO Capital Markets. The company was maintained on Tuesday, January 9 by Keefe Bruyette & Woods. On Monday, January 25 the stock rating was upgraded by Nomura to “Buy”. The stock has “Overweight” rating by Morgan Stanley on Wednesday, October 18. UBS maintained the stock with “Buy” rating in Friday, January 6 report. The firm has “Buy” rating given on Monday, August 31 by Evercore. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) earned “Outperform” rating by Wells Fargo on Thursday, January 25. Oppenheimer maintained The Goldman Sachs Group, Inc. (NYSE:GS) on Friday, January 29 with “Outperform” rating.

Since October 18, 2017, it had 0 insider purchases, and 8 insider sales for $28.24 million activity. Shares for $3.18M were sold by CHAVEZ R. MARTIN on Wednesday, January 31. VINIAR DAVID A sold 7,393 shares worth $1.81M. $6.13 million worth of The Goldman Sachs Group, Inc. (NYSE:GS) was sold by SCHWARTZ HARVEY M. SOLOMON DAVID M sold $5.77M worth of stock. $1.19 million worth of The Goldman Sachs Group, Inc. (NYSE:GS) was sold by GNODDE RICHARD J on Wednesday, October 18. Shares for $2.70M were sold by SALAME PABLO J.

The stock decreased 0.50% or $0.61 during the last trading session, reaching $121.26. About 595,466 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since February 17, 2017 and is uptrending. It has outperformed by 12.76% the S&P500.

Among 12 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Varian Medical Systems Inc. has $132 highest and $75 lowest target. $109’s average target is -10.11% below currents $121.26 stock price. Varian Medical Systems Inc. had 37 analyst reports since August 27, 2015 according to SRatingsIntel. Goldman Sachs downgraded the stock to “Sell” rating in Monday, September 28 report. The rating was downgraded by BTIG Research on Thursday, September 7 to “Neutral”. The firm has “Sell” rating given on Thursday, January 26 by Evercore. The rating was maintained by RBC Capital Markets on Monday, October 2 with “Hold”. Robert W. Baird maintained it with “Hold” rating and $99.0 target in Thursday, October 26 report. Citigroup maintained it with “Neutral” rating and $121 target in Monday, October 30 report. Goldman Sachs downgraded it to “Sell” rating and $98.0 target in Thursday, January 25 report. The company was maintained on Thursday, April 27 by RBC Capital Markets. The firm has “Sector Perform” rating given on Tuesday, December 22 by RBC Capital Markets. The rating was maintained by RBC Capital Markets with “Hold” on Friday, September 1.

Investors sentiment increased to 1.02 in Q3 2017. Its up 0.07, from 0.95 in 2017Q2. It improved, as 37 investors sold Varian Medical Systems, Inc. shares while 166 reduced holdings. 51 funds opened positions while 156 raised stakes. 89.98 million shares or 0.15% less from 90.12 million shares in 2017Q2 were reported. Hartford Inv Company reported 19,715 shares. 232,899 are owned by Hsbc Hldg Plc. Invesco invested 0.01% in Varian Medical Systems, Inc. (NYSE:VAR). Covington Inv Advsr holds 5,495 shares or 0.21% of its portfolio. Whittier Company holds 176 shares or 0% of its portfolio. Westpac holds 0.01% or 5,837 shares. Oregon Public Employees Retirement Fund invested in 35,815 shares. Ameritas Ptnrs reported 2,243 shares stake. Moreover, Alyeska Inv Gru L P has 0.2% invested in Varian Medical Systems, Inc. (NYSE:VAR). Menta Ltd Llc accumulated 11,279 shares. Tompkins Fincl stated it has 0.01% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Us Bancorporation De has 46,081 shares for 0.01% of their portfolio. Gw Henssler And Assoc owns 6,319 shares for 0.06% of their portfolio. Quantres Asset Mgmt owns 5,100 shares. Janney Montgomery Scott Ltd Liability Co stated it has 0.01% in Varian Medical Systems, Inc. (NYSE:VAR).

Since August 14, 2017, it had 0 insider buys, and 17 sales for $19.94 million activity. Another trade for 15,059 shares valued at $1.54M was made by WILSON DOW R on Friday, October 6. KENNEDY KOLLEEN T also sold $97,755 worth of Varian Medical Systems, Inc. (NYSE:VAR) on Wednesday, October 18. KUO JOHN W sold $93,575 worth of stock. $274,383 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares were sold by LARET MARK R. GUERTIN TIMOTHY E sold $1.11 million worth of stock. ECKERT R ANDREW also sold $578,594 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares.